Gemtuzumab Side Effects
Medically reviewed by Drugs.com. Last updated on Jan 2, 2025.
Applies to gemtuzumab: intravenous powder for solution.
Important warnings
This medicine can cause some serious health issues
Intravenous route (powder for solution)
Should only be used as single agent chemotherapy and not in combination chemotherapy regimens outside clinical trials.
Severe myelosuppression occurs when gemtuzumab is used at recommended doses.
Severe hypersensitivity reactions (including anaphylaxis), and other infusion-related reactions which may include severe pulmonary events have occurred with therapy.
Some of these hypersensitivity reactions have been fatal.
Patients with high peripheral blast counts may be at greater risk for pulmonary events and tumor lysis syndrome; physicians should consider leukoreduction with hydroxyurea or leukapheresis to reduce the peripheral white count to below 30,000/ microliters prior to administration of gemtuzumab.
Hepatotoxicity, including severe hepatic veno-occlusive disease (VOD), has been reported with therapy.
Physicians should monitor their patients carefully for symptoms of hepatotoxicity, particularly VOD.
Precautions
It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly. Blood tests are needed to check for any unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. If you think you have become pregnant while using the medicine, tell your doctor right away.
While you are being treated with gemtuzumab, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Gemtuzumab may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid persons who have taken oral polio vaccine within the last several months. Do not get close to them, and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.
Gemtuzumab can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
- If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
- Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin.
- Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.
- Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.
- Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.
- Avoid contact sports or other situations where bruising or injury could occur.
This medicine may cause serious types of allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor or nurse right away if you have blue lips, fingernails, or skin; difficult or fast breathing; dizziness, fainting, or lightheadedness; fever or chills; rash; trouble breathing or swallowing; or any swelling of your hands, face, or mouth after receiving this medicine.
Check with your doctor immediately if you have any symptoms of liver problems including skin and eyes turning yellow, dark brown-colored urine, right-sided abdominal or stomach pain, fever, or severe tiredness.
This medicine may cause a serious type of reaction called tumor lysis syndrome. Your doctor may give you a medicine to help prevent this. Call your doctor right away if you have a decrease or change in urine amount; joint pain, stiffness, or swelling; lower back, side, or stomach pain; a rapid weight gain; swelling of the feet or lower legs; or unusual tiredness or weakness.
Serious side effects of gemtuzumab
Along with its needed effects, gemtuzumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking gemtuzumab:
More common side effects
- black, tarry stools
- bloating or swelling of the face, arms, hands, lower legs, or feet
- blood in the stools or urine
- bluish color of the fingernails, lips, skin, palms, or nailbeds
- blurred vision
- burning or stinging of the skin
- chest pain
- chills
- confusion
- convulsions (seizures)
- cough or hoarseness
- cracked lips
- decrease or increase in urine
- diarrhea
- difficulty with swallowing
- dizziness
- dry mouth
- excessive sweating
- fainting
- fast or slow heartbeat
- fever
- flushed, dry skin
- fruit-like breath odor
- headache, sudden and severe
- heavy, nonmenstrual vaginal bleeding
- inability to speak
- increased thirst or hunger
- irregular heartbeat
- large, flat, blue, or purplish patches in the skin
- lightheadedness
- lower back, joint, or side pain
- loss of appetite
- mood changes
- muscle pain or cramps
- muscle trembling or twitching
- nausea or vomiting
- numbness or tingling in the hands, feet, or lips
- pain, difficulty, or burning while urinating
- painful cold sores or blisters on the lips, nose, eyes, or genitals
- pale skin
- palpitations
- persistent bleeding or oozing from puncture sites, mouth, or nose
- pinpoint red spots on the skin
- pounding in the ears
- rapid, shallow breathing
- rapid weight gain
- red or purplish patches or spots on the skin
- severe or continuing dull nervousness
- shortness of breath
- slurred speech
- small red or purple spots on the skin
- sneezing
- sore throat
- sores, ulcers, or white spots on the lips, tongue, or inside the mouth
- stomachache
- sweating
- swelling or inflammation of the mouth, face, fingers, feet, or lower legs
- swollen glands
- temporary blindness
- tightness in the chest
- tingling of the hands or feet
- troubled breathing, exertional
- unexplained nosebleeds
- unusual bleeding or bruising
- unusual tiredness or weakness
- unusual weight gain or loss
- weakness in the arm or leg on one side of the body, sudden and severe
- wheezing
- yellow eyes or skin
Other side effects of gemtuzumab
Some side effects of gemtuzumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- acid or sour stomach
- belching
- difficulty with moving
- dry, red, hot, or irritated skin
- full or bloated feeling or pressure in the stomach
- heartburn
- indigestion
- lack or loss of strength
- muscle pain or stiffness
- pain, swelling, or redness in the joints
- runny, stuffy nose
- stomach discomfort upset
- swelling of the abdominal or stomach area
- trouble with sleeping
For healthcare professionals
Applies to gemtuzumab: intravenous powder for injection.
Hematologic adverse events
- Very common (10% or more): Bleeding (25%), thrombocytopenia (24%), febrile neutropenia (18%)
- Common (1% to 10%): Hemorrhage
- Frequency not reported: Myelosuppression, anemia[Ref]
Other
- Very common (10% or more): Fever (79%), fatigue (46%)
- Common (1% to 10%): Pain
- Frequency not reported: Chills[Ref]
Gastrointestinal
- Very common (10% or more): Nausea (21%), vomiting (21%), constipation (21%), mucositis (21%)
- Common (1% to 10%): Diarrhea
- Postmarketing reports: Neutropenic colitis (sometimes fatal)[Ref]
Respiratory
- Common (1% to 10%): Pneumonia, lung edema
- Frequency not reported: Hypoxia, respiratory failure, dyspnea
- Postmarketing reports: Fungal lung infections (including Pulmonary mycosis and Pneumocystis jirovecii pneumonia) (sometimes fatal), interstitial pneumonia (sometimes fatal)[Ref]
Hepatic
- Very common (10% or more): Increased AST (40%), increased ALT (16%)
- Common (1% to 10%): Veno-occlusive liver disease (VOD) (sometimes fatal), hyperbilirubinemia[Ref]
Genitourinary
- Postmarketing reports: Hemorrhagic cystitis (sometimes fatal)
Genitourinary side effects have included vaginal hemorrhage (12%) and hematuria (10%)[Ref]
Immunologic
- Very common (10% or more): Infection (44%), sepsis (32%)
- Postmarketing reports: Bacterial infections (including Stenotrophomonas infection), potential for immunogenicity[Ref]
Renal
- Frequency not reported: Renal failure secondary to tumor lysis syndrome[Ref]
Cardiovascular
- Common (1% to 10%): Tachycardia
- Frequency not reported: QT interval prolongation, hypotension[Ref]
Dermatologic
- Very common (10% or more): Rash (16%)[Ref]
Nervous system
- Very common (10% or more): Headache (19%)[Ref]
Metabolic
- Very common (10% or more): Hypophosphatemia (64%), hypokalemia (57%), hyponatremia (44%), alkaline phosphatase increased (13%), aspartate aminotransferase increased (14%), alanine aminotransferase increased (10%)
- Common (1% to 10%): Blood bilirubin increased[Ref]
Hypersensitivity
- Frequency not reported: Hypersensitivity (including anaphylaxis)[Ref]
See also:
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Daunorubicin
Daunorubicin systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, acute ...
Revumenib
Revumenib systemic is used for acute lymphoblastic leukemia, acute myeloid leukemia, leukemia
Ivosidenib
Ivosidenib systemic is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Azacitidine
Azacitidine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine systemic is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic ...
References
1. "Product Information. Mylotarg (gemtuzumab ozogamicin)." Wyeth-Ayerst Laboratories
More about gemtuzumab
- Check interactions
- Compare alternatives
- Reviews (2)
- Dosage information
- During pregnancy
- Drug class: CD33 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Gemtuzumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.